CYDY could have cherry picked some of the patients and
CYDY could have cherry picked some of the patients and released it like Humanigen did with 12 on lenzilumab.
Instead we got a confusing press release without any real clear markers.
The struggle is real and this post stolen from gg100 at the IV biotech2k board says it all in a fun and slapstick sort of way...
<<I find the CYDY story so entertaining because of all the eclectic and improbable characters and events. The whole CYDY for covid thing is preposterous on its face, but then it happens.
My favorite comment is from the CEO on April 27:
...leronlimab, we were not on the map (for Covid19). Nobody thought we were on the map (for Covid19) and we didn't know either. Dr. Patterson and Dr. Scott Kelly had talked about it and then when Dr. Harish Seethamraju from Montefiore Medical Center heroically came and said "I need this" that started everything. Thank God for that...
They had no idea they were on the map!
And then Patterson suddenly chimes in with, "RANTES is the problem and leronlimab is the answer." If the script was submitted to Hollywood for review, it would be immediately dismissed as too fanciful.
Its like this ragtag bunch of characters is suddenly thrust into the strongest spotlight that has ever shined on biotech.
And now suddenly the obscure, off-the-map biotech with all of its oddball idiosyncracies is on full display for everyone to see.
The whole thing is so much like Forrest Gump. He is thrust into the situation without any prior experience, without any knowledge of how anything works, without any idea of how hard it might be, but he just keeps going and focuses on the next step he is about to take. And he enjoys chatting with anyone and everyone about each step as he goes. Certainly a fine way to conduct your business if you can make it work. I find it tremendously entertaining and refreshing. But this is investing and Forrest Gump was a fantasy. Right?>>
8
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
The Honoring of Leadership That Goes Beyond Business In a world where financial influence often feels like it funnels into the same familiar pockets, the news of Jacob Walthour Jr.'s upcoming recognition feels like a fresh breeze of change. The Alpha Phi Alpha's Alpha Alpha Lambda Chapter is rolling out the red carpet at its Centennial Gala for Walthour, throwing him into...
Continue Reading
A Big Day for American Savings Bank Buckled up yet? Because American Savings Bank has just shot onto the NYSE, raising a hefty $129 million. A solid start, I’d say, for a Honolulu-based outfit that now struts around with a valuation tipping beyond $1.03 billion. That’s what you get when you price more than eight million shares at $16 a pop. NYSE:ASBH is the new kid on...
Continue Reading
Finastra Steals the Spotlight in Payments Innovation When it comes to the modern world of finance, nothing screams ‘adapt or fade into oblivion’ like the payments industry. Well, here’s a reality check from QKS Group: Finastra has snatched the spotlight in their SPARK Matrix™ for 2026 as a powerhouse in integrated bank payments platforms. Clearly, this ain’t...
Continue Reading
California Families Get a Boost With New 529 Plan Offer Everywhere you turn, it's 'back to school' mania right now, and ScholarShare 529 aims to ride that wave by sweetening the pot for parents ready to think ahead. So here's the gist—California's official college savings plan is handing out a $50 gift card for new accounts opened between now and September 30th. Setting...
Continue Reading
Hold onto your hats, folks—Propensity just blasted its way to Number 70 on the Inc. 5000 for 2026. That's quite a leap from the 2,591 spot just last year. If you're scratching your head wondering what's behind this meteoric rise, it’s all about AI and knowing which buyer signals really matter. The AI Advantage in B2B The B2B marketing space isn't exactly the new Wild...
Continue Reading
Clear Stories, Stronger Growth If companies can't tell a clear story that their buyers understand and believe, they're destined to stagnate. That's the blunt reality kompeld is pushing with their H2 2026 Narrative Coherence Benchmark. The report scores 150 B2B tech companies on their narrative coherence, showing there's a stark correlation between storytelling and growth....
Continue Reading
Showcasing Cutting-Edge Home Energy Innovations It's that time of year again when the brightest innovators in home energy solutions get a nod from the Consortium for Energy Efficiency (CEE). This year's Integrated Home Competition spotlighted five trailblazing products that promise to reshape how we think about energy efficiency, demand flexibility, and sheer user comfort...
Continue Reading
A Bold Step in Healthcare Coordination No doubt about it, healthcare is a mess. It's like trying to patch a leaking ship with duct tape—point solutions here, add-ons there, and nothing truly working in harmony. And in storms in Lyric Health, claiming they've got the answer. They've launched an AI-powered Healthcare Operating System meant to unify these disjointed pieces...
Continue Reading
Red Banyan: A Powerhouse in Reputation Management Boy, have you ever watched a company rise through the ranks almost like a caffeine kick on a drowsy morning? That's Red Banyan for you. This outfit, right out of Fort Lauderdale, snagged the '2026 Best of Florida' award as the cream of the crop in the Business Consulting Firms category. It’s like taking home an Oscar in...
Continue Reading
Challenging the Haircare Norm with Confidence Goddess Maintenance Co. doesn't just draft a fresh play in the beauty industry playbook—it's ripping out the old pages and setting a new standard. This ain't your granny's haircare game anymore, folks. They're up for a 2026 BeautyMatter Award, a nod to their gut-busting innovation in the conditioner category with their star...
Continue Reading
Top 5 Most Recently Viewed Articles
ProVen Growth and Income VCT plc: Financial Performance Overview ProVen Growth and Income VCT plc has released its interim management statement detailing the performance for the period without discussing location specifics. This update reflects a commitment to transparency and provides insights into the company's financial health and strategic movements in investments....
Continue Reading
Stock Market Overview and Insights The stock market has been on an exciting upward trend, ending last week on a high note. Investors are keenly watching several economic indicators that can influence market performance, including retail sales and Federal Reserve communications. This week is particularly critical with the kickoff of the third-quarter earnings season. This...
Continue Reading
Arandell Corporation Completes Acquisition of Maple Grove Operations Saothair Capital Partners, a private equity firm dedicated to investing in middle-market manufacturing, is thrilled to announce that its portfolio company, Arandell Corporation, has successfully acquired the business and assets of the Maple Grove facility from the CJK Group. This strategic acquisition...
Continue Reading
Alright, let’s dive right into the recent shake-up at Century Therapeutics, Inc. (NASDAQ: IPSC). They’re not just shuffling the deck chairs; they’re bringing in some heavy hitters to lead their charge in the cell therapy arena. Dr. Morgan Conn has been brought on as Chief Financial Officer, while Dr. Chad Cowan steps in as Chief Scientific Officer. This isn’t your...
Continue Reading
Understanding the Legal Situation Surrounding Super Micro Computer Recently, a significant class action lawsuit has surfaced against Super Micro Computer, Inc. This legal action revolves around allegations of violations related to securities law, which could have notable implications for both the company and its investors. Details of the Allegations The lawsuit claims...
Continue Reading